drugset / Trial / NCT02054754

Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects

NCT02054754

Phase 1 Completed 40 enrolled e-Therapeutics PLC
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to test the safety and observe the pharmacokinetics (distribution and elimination of the drug) of the compound dexanabinol (ETS2101) in healthy male subjects following a single oral dose.

Timeline

Start
2014-01
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexanabinol Small molecule Oral

Indications